Atossa Therapeutics Inc (NASDAQ:ATOS)’s traded shares stood at 4.06 million during the last session, with the company’s beta value hitting 1.27. At the close of
In the last trading session, 2.0 million Atossa Therapeutics Inc (NASDAQ:ATOS) shares changed hands as the company’s beta touched 1.24. With the company’s per share
In last trading session, Atossa Therapeutics Inc (NASDAQ:ATOS) saw 1.64 million shares changing hands with its beta currently measuring 1.24. Company’s recent per share price
Atossa Therapeutics Inc (NASDAQ:ATOS) has a beta value of 1.21 and has seen 10.53 million shares traded in the last trading session. The company, currently
During the recent session, Atossa Therapeutics Inc (NASDAQ:ATOS)’s traded shares were 0.99 million, with the beta value of the company hitting 1.22. At the last
In today’s recent session, 1.49 million shares of the Atossa Therapeutics Inc (NASDAQ:ATOS) have been traded, and its beta is 1.23. Most recently the company’s
Atossa Therapeutics Inc (NASDAQ:ATOS)’s traded shares stood at 1.87 million during the last session, with the company’s beta value hitting 1.20. At the close of
In the last trading session, 3.16 million Atossa Therapeutics Inc (NASDAQ:ATOS) shares changed hands as the company’s beta touched 1.17. With the company’s per share
In the latest trading session, 0.79 million Atossa Therapeutics Inc (NASDAQ:ATOS) shares changed hands as the company’s beta touched 1.17. With the company’s most recent
In recent trading session, Atossa Therapeutics Inc (NASDAQ:ATOS) saw 0.48 million shares changing hands at last check today with its beta currently measuring 1.18. Company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
